The Effect of HER2 Amplification in HER2+Breast Cancer

被引:0
|
作者
Lee, M. K. [1 ]
Hurvitz, S. A. [1 ]
Tran, B. N. [1 ]
Fu, Y. [1 ]
Chung, D. U. [1 ]
Gornbein, J. [1 ]
Apple, S. K. [1 ]
Chang, H. R. [1 ]
机构
[1] Univ Calif Los Angeles, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P6
引用
收藏
页码:S45 / S45
页数:1
相关论文
共 50 条
  • [21] Efficacy of HER2 inhibitors in metastatic breast cancer by discordance in HER2 amplification status between primary and metastatic breast cancer
    Van Raemdonck, E.
    Berteloot, P.
    Laenen, A.
    Han, S.
    Van Nieuwenhuysen, E.
    Salihi, R.
    Concin, N.
    Vergote, I.
    Floris, G.
    Wildiers, H.
    Punie, K.
    Neven, P.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [22] Analysis of equivocal HER2 FISH amplification in breast cancer
    Sung, S. H.
    Moon, B. I.
    [J]. HISTOPATHOLOGY, 2012, 61 : 30 - 30
  • [23] HER2 amplification in tubular carcinoma of the breast
    Oakley, GJ
    Tubbs, RR
    Crowe, J
    Sebek, B
    Budd, GT
    Patrick, RJ
    Procop, GW
    [J]. LABORATORY INVESTIGATION, 2006, 86 : 38A - 38A
  • [24] HER2 amplification in tubular carcinoma of the breast
    Oakley, GJ
    Tubbs, RR
    Crowe, J
    Sebek, B
    Budd, GT
    Patrick, RJ
    Procop, GW
    [J]. MODERN PATHOLOGY, 2006, 19 : 38A - 38A
  • [25] HER2+breast cancer: Unresolved challenges
    Winer, E. P.
    [J]. CANCER RESEARCH, 2013, 73
  • [26] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Laura Morsberger
    Aparna Pallavajjala
    Patty Long
    Melanie Hardy
    Rebecca Park
    Rebecca Parish
    Azin Nozari
    Ying S. Zou
    [J]. Cancer Cell International, 22
  • [27] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Morsberger, Laura
    Pallavajjala, Aparna
    Long, Patty
    Hardy, Melanie
    Park, Rebecca
    Parish, Rebecca
    Nozari, Azin
    Zou, Ying S.
    [J]. CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [28] The frequency of HER2 amplification and the percentage of membrane staining in HER2 2 + invasive carcinomas of the breast
    Andrew H. S. Lee
    Ian O. Ellis
    [J]. Virchows Archiv, 2022, 481 : 327 - 327
  • [29] A phase I study of a DNA plasmid based vaccine encoding the HER2/neu (HER2) intracellular domain (ICD) in subjects with HER2+breast cancer
    Salazar, L. G.
    Slota, M.
    Wallace, D.
    Higgins, D.
    Coveler, A. L.
    Dang, Y.
    Childs, J.
    Bates, N.
    Waisman, J.
    Disis, M. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Activating HER2 mutations in HER2 gene amplification negative breast cancers.
    Bose, R.
    Kavuri, S. M.
    Searleman, A. C.
    Shen, W.
    Shen, D.
    Koboldt, D. C.
    Monsey, J.
    Li, S.
    Ding, L.
    Mardis, E. R.
    Ellis, M. J.
    [J]. CANCER RESEARCH, 2012, 72